As a result, CEBPD mRNA levels increased along with tumor grades and became significantly overexpressed in GBMs than in normal and low-grade gliomas (LGG; P < 0.05, Tukey HSD ANOVA; Fig. 2A). The gene discussed is CEBPD; the disease is central nervous system cancer.